Smilax Laboratories Limited is a fully backward integrated Active Pharmaceutical Ingredients manufacturing company catering to the generics market across the world. Smilax’s current standing is the outcome of its cutting-edge research, world class manufacturing, and truly global supply chain management.
Since its incorporation in 2004, Smilax has grown to become a reliable supplier of generic API products in the global market. Smilax supports entrepreneurial spirit, culture of creativity and innovation that makes the difference in the lives of people.
A unique portfolio of high quality and difficult-to-make pharmaceutical products fuels our targeted growth strategy. We offer high-quality, affordable generic medications that help reduce healthcare costs around the world.